Activation of diverse signalling pathways by oncogenic PIK3CA mutationsXinyan Wu, Akhilesh Pandey, Praveen Kumar et al.|Nature Communications|2014Cited by 86
Global phosphotyrosine survey in triple-negative breast cancer reveals activation of multiple tyrosine kinase signaling pathwaysXinyan Wu, Akhilesh Pandey, Muhammad Saddiq Zahari et al.|Oncotarget|2015Cited by 67
The non-receptor tyrosine kinase TNK2/ACK1 is a novel therapeutic target in triple negative breast cancerXinyan Wu, Akhilesh Pandey, Muhammad Saddiq Zahari et al.|Oncotarget|2016Cited by 60
Phosphoproteomic Analysis Identifies Focal Adhesion Kinase 2 (FAK2) as a Potential Therapeutic Target for Tamoxifen Resistance in Breast CancerXinyan Wu, Akhilesh Pandey, Muhammad Saddiq Zahari et al.|Molecular & Cellular Proteomics|2015Cited by 56